Price
Target price
€7.88
€7.88
0.180%
-
0.180%
-
06:47 / Tradegate
WKN: A1XEAC / Symbol: CNCE / Name: Concert Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Concert Pharmaceuticals Inc. Stock
Concert Pharmaceuticals Inc. gained 0.180% compared to yesterday.
So far the community has only identified positive things for Concert Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Concert Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Concert Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Concert Pharmaceuticals Inc. | 0.180% | 0.000% | 0.000% | - | 56.305% | - | - |
| Brainstorm Cell | 0.730% | -2.837% | -0.725% | 1.182% | 93.230% | -54.711% | - |
| Sorrento Therapeutics Inc. | -24.520% | 0.000% | 0.000% | -81.488% | -65.296% | -93.763% | - |
| Atara Biotherapeutics Inc. | -5.350% | -15.529% | -32.974% | -66.065% | -44.577% | -83.812% | - |
Comments
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CNCE provided by MarketBeat
